Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorder of Endocrine Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00222469
What this trial is testing

Combination Chemotherapy for 1st Line Treatment of Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
University of Oklahoma 50
Post-approval studies (Phase 4)UnknownNCT04357483
What this trial is testing

Effect of Thrombin-containing Collagen-based Hemostatic Matrix

Who this might be right for
Pancreatic Tumor
Asan Medical Center 60
Not applicableStudy completedNCT04920019
What this trial is testing

Opioid Sparing Effect of Thoracic Epidural Analgesia for Open Upper Abdominal Surgery

Who this might be right for
HepatomaPancreas Cancer
Mahidol University 140
Testing effectiveness (Phase 2)UnknownNCT04289792
What this trial is testing

Split-course SBRT for Borderline Resectable and Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Fujian Medical University Union Hospital 27
Not applicableStudy completedNCT05483075
What this trial is testing

Feasibility of a Health Care Provider Guided Exercise Intervention Prior to Surgical Resection of Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
NYU Langone Health 16
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05637567
What this trial is testing

Perioperative Platelet Inhibition With Acetylsalicylic Acid in Patients With Resectable Tumors of the Pancreatic Head

Who this might be right for
Pancreatic Cancer Resectable
German Cancer Research Center 170
Not applicableTemporarily pausedNCT06653192
What this trial is testing

EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction (CARPEDIEM Trial)

Who this might be right for
Malignant Biliary ObstructionPancreatic CancerBiliary Tract Neoplasms
Hospital Universitari de Bellvitge 120
Testing effectiveness (Phase 2)Study completedNCT00075439
What this trial is testing

Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors

Who this might be right for
GastrinomaGlucagonomaInsulinoma+6 more
National Cancer Institute (NCI) 90
Not applicableUnknownNCT03178812
What this trial is testing

Role of the Cystic Fluid Interleukins and Tumor Necrosis Factor (TNF) Levels in Characterizing Pancreatic Cysts Detected by Endoscopic Ultrasound (EUS)

Who this might be right for
Pancreatic Cancer
Hillel Yaffe Medical Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT04924075
What this trial is testing

Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

Who this might be right for
Pheochromocytoma/ParagangliomaPancreatic Neuroendocrine TumorVon Hippel-Lindau Disease+2 more
Merck Sharp & Dohme LLC
Not applicableLooking for participantsNCT07760012
What this trial is testing

68Ga-SorB PET/CT Imaging in Patients With Solid Tumors

Who this might be right for
Melanoma (Skin Cancer)Hepatocellular CarcinomaLung Cancer+3 more
Peking University Third Hospital 50
Not applicableLooking for participantsNCT05356039
What this trial is testing

Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreas CancerPancreas NeoplasmPancreas Disease+6 more
Umeå University 300
Not applicableEnded earlyNCT05188586
What this trial is testing

New Onset Diabetes Management for Earlier Detection of Pancreatic Cancer (NODMED)

Who this might be right for
Pancreatic Cancer
ClearNote Health 26
Not applicableStudy completedNCT03982446
What this trial is testing

Germline Mutations in Pancreatic Adenocarcinoma

Who this might be right for
Germline Mutation AbnormalityPancreatic CancerPredisposition, Genetic+1 more
Hellenic Cooperative Oncology Group 549
Not applicableUnknownNCT05831488
What this trial is testing

Assessing the Accuracy of Seismofit® as an Estimate of VO2 Peak in Patients With Hepato-pancreato-biliary, Colorectal, and Gastro-oesophageal Cancer

Who this might be right for
Hepato-Biliary Carcinoma in Situ NosPancreatic CancerColorectal Cancer+2 more
Royal Marsden NHS Foundation Trust 35
Not applicableLooking for participantsNCT04370574
What this trial is testing

Discovery of Soluble Biomarkers for Pancreatic Cancer Using Innovative All-Patient Inclusive Methodology

Who this might be right for
Pancreatic Neoplasms
University Hospital, Montpellier 200
Testing effectiveness (Phase 2)Study completedNCT02611024
What this trial is testing

Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors

Who this might be right for
Advanced Solid TumorsGlioblastomaSoft Tissue Sarcoma (Excluding GIST)+9 more
PharmaMar 316
Testing effectiveness (Phase 2)UnknownNCT04902261
What this trial is testing

Tislelizumab Combined With Nab-paclitaxel and Gemcitabine for Recurrent Pancreatic Cancer

Who this might be right for
Recurrent Pancreatic Cancer
Changhai Hospital 140
Not applicableStudy completedNCT01876069
What this trial is testing

Comparing Newly Developed PreCore Needle With Conventional Fine Needle in Suspected Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Samsung Medical Center 65
Testing effectiveness (Phase 2)Study completedNCT04493060
What this trial is testing

Niraparib and Dostarlimab for the Treatment of Germline or Somatic BRCA1/2 and PALB2 Mutated Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Ductal AdenocarcinomaStage IV Pancreatic Cancer AJCC v8
Mayo Clinic 22
Next Page
355